Long-time Portola Pharmaceuticals (NASDAQ:PTLA) CEO Bill Lis has decided to retire, and the surprising decision is boosting bullish investors' optimism: Some feel that the C-suite shake-up presents the perfect opportunity for a suitor to come knocking on this biotech's door.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,